Alexander, also the immediate past president of the Obesity Medicine Association, calls it the disease of diseases, driving at least 250 conditions
Plus, rapid weight loss associated with GLP-1s may contribute to gallstone formation, while the emotional and psychological impacts of sudden changes in appetite and body composition remain unstudied
Eric Reiman, the executive director of the Banner Alzheimers Institute told Being Patient
3 Looking ahead Theres promising emerging data to suggest potential benefits of using GLP-1s for other health conditions
These results established tirzepatide as the most potent agent in the current pharmacologic armamentarium for obesity
They help raise insulin and suppress the hormone glucagon, which plays a role in both appetite and Type 2 diabetes